© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
The Smart Choice
Innovation
13/02/2017The Smart Choice

Remfry & Son is a well-established law firm which continues law practice first established in 1827 by its founder Mr. Henry Oliver Remfry of England U.K. and carried on under the name of Remfry & Son by Mr. Chughtai Mirza Jamiluddin, Advocate. Professional pra

Read Full PostRead - Eye Icon
Get exclusive, safe access to Telegram’s Gram tokens with professional cryptocurrency exchange DSX
Finance
01/10/2019Get exclusive, safe access to Telegram’s Gram tokens with professional cryptocurrency exchange DSX

DSX, the professional cryptocurrency exchange, will be the only UK based, FCA registered platform offering investors the chance to buy Telegram’s Gram tokens when they go on public sale.

Read Full PostRead - Eye Icon
Why Your IT Is Important To Your Physical Security
Innovation
22/02/2023Why Your IT Is Important To Your Physical Security

IT acts as the first barrier in your physical security system and protects your cloud-based physical security features from interception. Merging digital and physical security is necessary to protect your building and the assets stored within your facilities.

Read Full PostRead - Eye Icon
Creating A Lead Generation Strategy From Cold To Hot Leads
News
05/09/2022Creating A Lead Generation Strategy From Cold To Hot Leads

The lifeblood of any business is finding new clientele while retaining your old ones.  Customers are like the focal point where the two arms of a business rest. On the one side are new customers; on the other are returning customers. 

Read Full PostRead - Eye Icon
3 Proven Strategies for Mastering the Art of Closing High-Stake M&A Deals
M&A
31/05/20233 Proven Strategies for Mastering the Art of Closing High-Stake M&A Deals

Mergers and acquisitions have always been risky undertakings that can end without profit. The most complex transactions can rightfully involve M&A that can drag on for years without any visible results.

Read Full PostRead - Eye Icon
Understanding Personal Injury Legal Services
News
27/05/2024Understanding Personal Injury Legal Services

When we hear the term “personal injury,” we often think of obvious physical wounds like broken bones, cuts, or bruises. However, personal injury cases encompass much more than just visible harm. Personal injury law recognizes that accidents and neg

Read Full PostRead - Eye Icon
Biocon to go Ahead with Syngene IPO, Listing Likely in July
Finance
19/05/2015Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biotechnology major Biocon on Wednesday filed a prospectus with market regulator Securities and Exchange Board of India (Sebi) for the Initial Public Offer (IPO) of its research arm, Syngene, through which it aims to raise around Rs 600 crore for funding resea

Read Full PostRead - Eye Icon
Creating Innovative Digital Content Solutions
Innovation
08/05/2019Creating Innovative Digital Content Solutions

Integra is a leading digital content services company providing innovative source-to-publish solutions to global publishers and digital learning solutions to organizations across diverse industry verticals. Following their success in AI’s Global Excellence A

Read Full PostRead - Eye Icon
Forex Broker, Orbex, Celebrates International Women’s Day with ‘Invest Like Her’ Campaign
Finance
09/03/2015Forex Broker, Orbex, Celebrates International Women’s Day with ‘Invest Like Her’ Campaign

In celebration of the International Women's Day, Forex broker, Orbex, has launched a campaign in honour of the women in finance.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow